| Nov 21 |
Melt reports topline outcomes from trial of MELT-300 for cataract surgery
|
| Nov 20 |
Morgan Stanley lists hedge funds’ largest Q3 ownership increases in Russell 1000 stocks
|
| Nov 17 |
Avid Bioservices, Inc. (CDMO): A Bull Case Theory
|
| Nov 13 |
EU regulators seek info from rivals, customers in Catalent sale to Novo Holdings - Reuters
|
| Nov 13 |
EU regulators quiz Novo Nordisk, Catalent rivals on $16.5 billion deal
|
| Nov 6 |
Catalent's Stock Gains Despite Q1 Earnings Miss, Gross Margin Up
|
| Nov 5 |
Catalent misses Q1 revenue estimates ahead of $16.5 billion deal close with Novo Holdings
|
| Nov 5 |
Catalent (CTLT) Reports Q1 Loss, Lags Revenue Estimates
|
| Nov 5 |
Catalent GAAP EPS of -$0.71, revenue of $1.02B
|
| Nov 5 |
Catalent: Fiscal Q1 Earnings Snapshot
|
